Latest Breaking News On - Clin cardiol - Page 4 : comparemela.com

New REDUCE-IT® Analyses Show VASCEPA® (icosapent ethyl) Associated with 29 Percent Relative ...

Analysis Also Found IPE Was Associated with a 41% Reduction in Total Events Compared with Placebo

Celebrate Pharmacists Who Are Trailblazers in MTM

American Pharmacists Month is an important time to recognize pharmacists who are innovators in medication therapy management

Benefits and Efficiencies Abound, but AI Misses the Humanity of Care

Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy for oncologists treating patients in a community setting.

Medically, you might be interested in...

A regular series on the latest clinical studies from around the world – and what they mean ‘in practice’ – compiled and written by Clare GP Dr Ray

Amarin Corporation plc: Latest Research Evaluating Clinical Benefits of VASCEPA®/VAZKEPA® (icosapent ethyl) to be Presented at the European Society of Cardiology (ESC) Congress